CNY 19.59
(9.99%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.38 Billion | 542.57 Million | 449.88 Million | 740.06 Million | 763.05 Million | 594.33 Million |
Net Income | 424.85 Million | 889.29 Million | 784.94 Million | 593.43 Million | 844.06 Million | 823.04 Million |
Depreciation & Amortization | 351.8 Million | 274.87 Million | 203.05 Million | 129.75 Million | 113.43 Million | 113.51 Million |
Deferred income taxes | -273.95 Million | -155.12 Million | -160.34 Million | -72.89 Million | -29 Million | -3.28 Million |
Stock-based compensation | 59.39 Million | 78.49 Million | 45.27 Million | 9.01 Million | 34.08 Million | - |
Change in working capital | 574.79 Million | -926.38 Million | -673.16 Million | -71.6 Million | -258.92 Million | -271.75 Million |
Other non-cash items | 399.06 Million | 381.33 Million | 250.13 Million | 152.35 Million | 59.4 Million | -70.46 Million |
Investing Cash Flow | -683.54 Million | -440.6 Million | -392.85 Million | -422.84 Million | -28.34 Million | -478.3 Million |
Investments in PPE | -434.07 Million | -435.57 Million | -418.04 Million | -479.21 Million | -295.39 Million | -211.49 Million |
Acquisitions | 13.57 Million | 9.74 Million | 10.16 Million | 1.96 Million | 3.03 Million | 1.63 Million |
Investment purchases | -118.37 Million | -24.93 Million | -4.93 Million | -9.27 Million | -762 Million | -6.54 Million |
Sales/Maturities of investments | 65.37 Million | 17.96 Million | 27.96 Million | 41.67 Million | 39.86 Million | 26.29 Million |
Other Investing Activities | -210.04 Million | -7.79 Million | -7.99 Million | 22 Million | 986.14 Million | -288.21 Million |
Financing Cash Flow | -784.24 Million | 2.18 Billion | -31.14 Million | -296.34 Million | -302.46 Million | -137.08 Million |
Debt repayment | -411.86 Million | -2.07 Billion | -1.11 Billion | -283.22 Million | -41.33 Million | -19.84 Million |
Dividends payments | -58.89 Million | -58.32 Million | -58.32 Million | -64.16 Million | -64.16 Million | -85.37 Million |
Common Stock Repurchased | -39.99 Million | - | - | - | - | - |
Common Stock Issuance | -3.63 Million | - | - | -3.45 Million | - | - |
Other Financing Activities | -191.67 Million | 4.35 Billion | 1.16 Billion | -216.72 Million | -195.81 Million | -31.86 Million |
Accounts receivables | -618.56 Million | 60.43 Million | -71.26 Million | -15.65 Million | -124.87 Million | -60.91 Million |
Accounts payables | 728.7 Million | -77.4 Million | 1.31 Billion | 725.89 Million | 26.02 Million | -8.47 Million |
Inventory | 505.12 Million | -754.28 Million | -1.75 Billion | -708.94 Million | -131.06 Million | -199.07 Million |
Other working capital | -40.46 Million | -155.12 Million | -160.34 Million | -72.89 Million | -29 Million | -72.68 Million |
Cash at beginning of period | 4.32 Billion | 1.98 Billion | 1.96 Billion | 1.97 Billion | 1.53 Billion | 1.55 Billion |
Cash at end of period | 4.34 Billion | 4.29 Billion | 1.98 Billion | 1.96 Billion | 1.97 Billion | 1.53 Billion |
Capital Expenditure | -434.07 Million | -435.57 Million | -418.04 Million | -479.21 Million | -295.39 Million | -211.49 Million |
Effect of forex changes on cash | 984.7 Thousand | 27.95 Million | -9.9 Million | -26.05 Million | 1.74 Million | -346.29 Thousand |
Net cash flow / Change in cash | 24.92 Million | 2.31 Billion | 15.98 Million | -5.18 Million | 433.99 Million | -21.39 Million |
Free Cash Flow | 954.15 Million | 107 Million | 31.84 Million | 260.85 Million | 467.66 Million | 382.84 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 137.61 Million | 113.61 Million | 11.55 Million | 122.04 Million | 424.85 Million | 104.52 Million |
Depreciation & Amortization | - | 85.81 Million | 85.81 Million | 91.25 Million | 351.8 Million | -134.86 Million |
Deferred income taxes | - | - | - | 94.51 Million | -273.95 Million | -52.26 Million |
Stock-based compensation | - | 19.6 Million | - | 59.39 Million | 59.39 Million | -31.45 Million |
Change in working capital | - | -852.98 Million | - | -153.9 Million | 574.79 Million | 216.31 Million |
Other non-cash items | 809.11 Million | 316.26 Million | -1.91 Billion | 723.47 Million | 399.06 Million | 779.49 Million |
Investing Cash Flow | -855.47 Million | -507.68 Million | -264.83 Million | -411.11 Million | -683.54 Million | -72.72 Million |
Investments in PPE | -134.13 Million | -143.21 Million | -217.19 Million | -172.88 Million | -434.07 Million | -74.51 Million |
Acquisitions | 2.26 Million | 248.87 Thousand | 1.01 Million | 10.98 Million | 13.57 Million | -9.99 Million |
Investment purchases | -100 Million | -394.72 Million | -50 Million | -30.02 Million | -118.37 Million | -15 Million |
Sales/Maturities of investments | 71.25 Million | 30 Million | 1.33 Million | 1.37 Million | 65.37 Million | 16.27 Million |
Other Investing Activities | -692.59 Million | 30 Million | -47.64 Million | -220.55 Million | -210.04 Million | 10.5 Million |
Financing Cash Flow | -614.57 Million | -285.57 Million | 1.16 Billion | -48.23 Million | -784.24 Million | -332.96 Million |
Debt repayment | -544.8 Million | -70.93 Million | -1.2 Billion | -5.1 Million | -411.86 Million | -283.79 Million |
Dividends payments | -11.5 Million | -158.39 Million | -6.1 Million | -58.89 Million | -58.89 Million | -59.28 Million |
Common Stock Repurchased | 13.09 Million | -13.09 Million | - | -39.99 Million | -39.99 Million | -3.63 Million |
Common Stock Issuance | - | - | - | -3.63 Million | -3.63 Million | 3.63 Million |
Other Financing Activities | -58.27 Million | -308.23 Million | -31.94 Million | 118.52 Million | -191.67 Million | 12.98 Million |
Accounts receivables | - | -457.05 Million | - | -618.56 Million | -618.56 Million | 911.14 Million |
Accounts payables | - | - | - | - | 728.7 Million | 35.03 Million |
Inventory | - | -477.15 Million | - | 505.12 Million | 505.12 Million | -694.83 Million |
Other working capital | - | 81.22 Million | - | -40.46 Million | -40.46 Million | -35.03 Million |
Cash at beginning of period | 2.76 Billion | 3.3 Billion | 4.21 Billion | 3.65 Billion | 4.32 Billion | 3.19 Billion |
Cash at end of period | 2.22 Billion | 2.82 Billion | 3.21 Billion | 4.34 Billion | 4.34 Billion | 3.6 Billion |
Capital Expenditure | -134.13 Million | -143.21 Million | -217.19 Million | -172.88 Million | -434.07 Million | -74.51 Million |
Effect of forex changes on cash | -568.98 Thousand | 953.67 Thousand | 251.62 Thousand | 133.3 Million | 984.7 Thousand | -69.58 Million |
Net cash flow / Change in cash | -544.69 Million | -478.84 Million | -999.79 Million | 699.46 Million | 24.92 Million | 406.46 Million |
Free Cash Flow | 812.59 Million | 200.85 Million | -2.11 Billion | 763.88 Million | 954.15 Million | 807.22 Million |
LRKKF
BPLPHARMA
3091
NTCIND
600983
8967